Senior insider sale
EVP, CHIEF SCIENTIFIC OFFICER at EDITAS MEDICINE, INC. — senior position signals high conviction
$17.4K
6.36K shares
What this filing means
BURKLY LINDA plans to sell 6.36K shares of EDITAS MEDICINE, INC. valued at approximately $17.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/31/2026ACC: 0001650664-26-000085
Officer· EVP, CHIEF SCIENTIFIC OFFICER
Since Mar 2026
6.36K
Shares to sell
$17.4K
Approx. market value
1.55K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Vesting
Equity Compensation
9/2/2026
1.55KTotal acquired1.55K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/2/2026 | Restricted Stock Unit Vesting Equity Compensation | 1.55K | — |
| Total | 1.55K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
4.93K
Market value
$13.2K
7/28/2026
—Completed
Units to sell
731.00
Market value
$2.0K
6/3/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
700.00
Market value
$2.3K
9/3/2026
Total
Units
6.36K
Value
$17.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/28/2026 | 4.93K | $13.2K | — | Completed |
6/3/2026 | 731.00 | $2.0K | — | Completed |
| Planned — Approximate Date | ||||
9/3/2026 | 700.00 | $2.3K | NASDAQ | Planned |
| Total | 6.36K | $17.4K | ||